To test whether the increased appearance of these cell surface adhesion molecules by PNA-mediated MCP-1 and IL-6 secretion affects tumour cell-endothelial interaction, HUVECs were treated with PNA, without or with PNA-binding glycoprotein ASF or antibodies to MCP-1 and IL-6. This evidence concerns the gene CCL2 and neoplasm.